IDS Photo Cropped_0041_INSTRUMENTATION_2

IDS-iSYS Total Testosterone Launch

We are pleased to announce the launch of the IDS-iSYS Total Testosterone assay in the European market – a fully automated assay for use with the IDS-iSYS Multi-Discipline Automated System. The launch of the IDS-iSYS Total Testosterone assay is the latest addition to the new fertility (steroid hormones) portfolio. The IDS-iSYS Total Testosterone assay measures […]

IDS Photo Cropped_0019_VASCULAR

Now Available: IDS-iSYS 17-OH Progesterone Assay

We are pleased to announce the launch of the IDS-iSYS 17-OH Progesterone assay in the European market – a fully automated assay for use with the IDS-iSYS Multi-Discipline Automated System. The launch of the IDS-iSYS 17-OH Progesterone assay is the first product released as part of the upcoming fertility (steroid hormones) portfolio. The IDS-iSYS 17-OH […]

IDS Photo Cropped_0040_IDS 129672

IDS-iSYS Salivary Cortisol Hypertension Assay Now Available.

Immunodiagnostic Systems Holdings plc (IDS), a leading solution provider to the clinical laboratory diagnostic market, today announced the launch of the IDS-iSYS Salivary Cortisol assay in Europe and other markets outside USA. The IDS-iSYS Salivary Cortisol is a fully automated assay for use with the IDS-iSYS Multi-Discipline Automated System family. The launch of this assay […]

FDA CLEARANCE OF DIRECT RENIN ASSAY ON IDS-ISYS

IDS join Pan-European APPROACH consortium, to provide improved drug development and prognosis tools for osteoarthritis patients worldwide.

Immunodiagnostic Systems Limited is a leading in vitro diagnostic solutions provider to the clinical and research laboratory markets.  We are committed to providing highly accurate and reproducible immunoassays and offer the most promising markers according to BIPED (Burden of disease, Investigative, Prognostic, Efficacy of intervention and Diagnostic) criteria to analyse cartilage related events in body […]